Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[sample type]	Characteristics[cell type]	Characteristics[disease]	Characteristics[tumor grade]	Characteristics[tumor stage]	Characteristics[sex]	Characteristics[ancestry category]	Characteristics[race]	Characteristics[case status]	characteristics[age]	Characteristics[case submitter id]	Characteristics[external case id]	Characteristics[sample submitter id]	assay name	Technology Type	comment[instrument]	comment[experiment type]	comment[file uri]	comment[data file]	comment[md5sum]	comment[fractionation method]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 1	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f13.raw	ed9e1b4863458bdfe67a2aaf1f553836	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 2	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f21.raw	22ef5b325f5f5562f76071cfbbc8aa65	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 3	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f18.raw	6fcea126206642914504d62c77ffb93e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 4	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f15.raw	33b32869b68f1d8fbf230643cb9f8d59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 5	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f17.raw	9e3df8f6fa8896ab641b0b463c6920b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 6	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f14.raw	ddbb3eeeeb2fd036f96ed03b6d83dc4d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 7	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f10.raw	6d561114023421ff2c891662921ec051	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 8	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f12.raw	e4e98e51ada05bd4807224e8b9a66064	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 9	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f03.raw	b421657b3764ec857c1d2ca2dee3381c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 10	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f19.raw	5c80ee21f45e7c2713e374b31a64ee50	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 11	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f08.raw	59ac3e267820332d83f7eb14cb55fd68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 12	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f20.raw	5cf408ddb09f7de1b10c4a4ee995773e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 13	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f06.raw	79c9dfa2fa9a3ec03501976eaaeae4ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 14	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f22.raw	2b288d22a95202de9e4d95946ff11aa2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 15	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f16.raw	e1ec4124b8704ebf941f7f700795c35d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 16	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f07.raw	7c90a96f29246d07247401d360391cb3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 17	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f05.raw	3b8f1e0fe6ff6b83da077a211be1f49a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 18	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f24.raw	25869779fda0ff0d43f1c2223fa46971	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 19	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f23.raw	4fdd6fd3551e567d94bac4e65a208a52	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 20	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f02.raw	aee1b927c36940446be6d8c7a4a445a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 21	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f09.raw	5c284af97ddcc3ab0f5f3d2f7c082cf6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 22	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f11.raw	91cd9ec63cad7f2dca5ea0b88dd3d8a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 23	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f04.raw	dd4c0aa1323c1b7eed30681399c4e7b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 24	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	01CPTAC_BCprospective_W_BI_20160911_BL_f01.raw	555a18d71b8c505540d51cca8354d43d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ef52c640-13a9-4855-9ce2-0be77a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	ef52c640-13a9-4855-9ce2-0be77a	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6d34d499-167e-42aa-9790-316fca_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR043	GDC: 7b9ae31b-3b14-45c5-a1ef-ba5abf634f0f	6d34d499-167e-42aa-9790-316fca	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2e700669-85b0-43fa-a9c7-3eaf5a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR049	GDC: c548752a-095a-413e-b99d-dd8b6412b924	2e700669-85b0-43fa-a9c7-3eaf5a	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
079b5600-6afc-4785-bb22-48cfab_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	079b5600-6afc-4785-bb22-48cfab	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0bb9d596-774e-452b-9c89-a6643c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR010	GDC: a313ced2-f402-41ec-96e8-6f3da137d9bf	0bb9d596-774e-452b-9c89-a6643c	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
31b13596-554e-452f-91a4-7e67a8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR003	GDC: 27e868aa-dbf2-42b3-889d-72f17787b965	31b13596-554e-452f-91a4-7e67a8	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12ce8313-6c54-4bee-a996-1aa7f8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	12ce8313-6c54-4bee-a996-1aa7f8	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
392b8aa4-9f99-4250-b693-326260_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR017	GDC: 2d03b036-d027-471a-b1f6-ec53e1958a8e	392b8aa4-9f99-4250-b693-326260	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
09659708-7747-4d59-a3b9-e221e0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	White	Qualified	not available	01BR017	GDC: a1c7b7b9-b8c8-48c3-9420-55497f9318fd	09659708-7747-4d59-a3b9-e221e0	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 25	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/01CPTAC_BCprospective_Proteome_BC_20160911/01CPTAC_BCprospective_Proteome_BC_20160911_raw/01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	01CPTAC_BCprospective_W_BI_20160911_BL_fA.raw	9346c7a8dd9e1a79a9613f63caf5a5e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 26	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f06.raw	1387d3fc1e061aa02328a6fb4b36f852	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 27	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f03.raw	145e6b2d0bf68c8201eac87acfdce647	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 28	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f04.raw	a3029398aac09ac7d39d3a98eef5d2a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 29	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f20.raw	9bd973c6a3c6f690abc045267c0976a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 30	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f02.raw	db2d9d7f91ca95dd0a307cd09df9eee1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 31	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f05.raw	b02a2eebdadc7afd329a32373e132407	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 32	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f24.raw	a933019f4a3abdb7c7bcd0d1dd5f531e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 33	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f19.raw	5dea0473d0bdda47ec7546a2ec6ed04a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 34	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f09.raw	f769d7fceb852408b8b52470677b5497	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 35	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f18.raw	bcf6c1b2805821c62c9082863c6f2c6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 36	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f21.raw	88a54ab6fb26bbd490bc4e832a41fedc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 37	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f14.raw	f5ced1475dcce67a1fef9e3bb55e62ed	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 38	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f13.raw	cbb591a84a231b33bbedeccc7f0c682c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 39	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f16.raw	8f74eb515b12cafc85c7c0bd0f06c7cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 40	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f01.raw	27dd7e42699eaa3466aec27891cde1ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 41	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f23.raw	7c848861ed5925ac85f394e05b619f7b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 42	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f22.raw	f6d3379d6201551cf95d388a7cf84467	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 43	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f12.raw	1446610a2d6cacc608d4db0f6584dca3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 44	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f15.raw	f6e14cbcde670fef9a28ab89a48bf060	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 45	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f07.raw	cdefeeeed44503cc15a66d5058c6b03b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 46	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f17.raw	93ab7276a378f6801751ebd93177bf07	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 47	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	02CPTAC_BCprospective_W_BI_20160913_BL_fA.raw	ffd8341773d45045a59dd873be6a189b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 48	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f11.raw	6a1bcf36e62e96ddb16652ec2e2be561	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 49	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f08.raw	2f73270f55cc77acfe28435a94caa084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3799eeb5-c966-4059-a78f-ace269_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Performed	Female	Hispanic or Latino	not available	Qualified	not available	06BR006	GDC: 46ca1147-0e6c-42bb-bcec-0cb1260d1a29	3799eeb5-c966-4059-a78f-ace269	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
150c2086-1815-40d2-bc5d-8eeb48_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	09BR005	GDC: 7212d772-6938-4a6d-b7d1-a58c191ac88c	150c2086-1815-40d2-bc5d-8eeb48	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241c8dec-b317-4794-8cc2-07c14c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241c8dec-b317-4794-8cc2-07c14c	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
42cc89e1-a896-4f57-b8d9-e7fe56_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR015	GDC: 54e89878-a1bc-4f5a-9d68-4842a469586e	42cc89e1-a896-4f57-b8d9-e7fe56	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8d7fc1ef-a0ac-44bb-8381-1444a0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	8d7fc1ef-a0ac-44bb-8381-1444a0	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
17d55745-4ab3-4a80-a182-af938b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR001	GDC: be37f1f7-2f98-4f74-bc04-6dd2ae2afcad	17d55745-4ab3-4a80-a182-af938b	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e5e1306b-719e-4c3e-b85b-fd1231_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	01BR032	GDC: a701a3bb-aaa6-41a3-9e38-d1472d39eb21	e5e1306b-719e-4c3e-b85b-fd1231	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
92862537-5f30-47db-a3e2-cc9d0c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR045	GDC: 9ac281b9-012c-42d8-a551-fc89f7d0e352	92862537-5f30-47db-a3e2-cc9d0c	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 50	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/02CPTAC_BCprospective_Proteome_BC_20160913/02CPTAC_BCprospective_Proteome_BC_20160913_raw/02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	02CPTAC_BCprospective_W_BI_20160913_BL_f10.raw	926c50db1ed08a93888adc9da92bd728	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 51	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f02.raw	545a4c727ad27ab5c279a2e450ee2382	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 52	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f16.raw	1e338c3a830d8d664d15ca3d1359131e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 53	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f18.raw	2eef49a74830a9c994975036a9c2b547	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 54	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f13.raw	d5a19afc48c2f06b3cc7cb1dfc8c25b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 55	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f04.raw	0a3500fe44bc1218d23aa3b10f525731	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 56	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f03.raw	32e60f56fb89e44afe7b478351122d08	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 57	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f10.raw	40072c75090db0b631c82c3e1fa1e816	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 58	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f21.raw	a068e8b3e5381ba5537721152fa8d7af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 59	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f01.raw	38d47da51350fb7f0202fecc58315809	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 60	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f09.raw	ec335d470f63e4aabc9d9afb7e61cac7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 61	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f08.raw	f15eae90b9509850f63fc223c611ec67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 62	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f23.raw	04f42e59861f54b57b8181ae3113d357	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 63	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f24.raw	f76f443db90d6f07ea9c172248153580	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 64	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	03CPTAC_BCprospective_W_BI_20160919_BL_fA.raw	1133f814e2bd5a5eecf3d343f75a18ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 65	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f12.raw	3d0fc6857389e2a329d896bfde1a14d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 66	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f11.raw	6011b5ed3cdbfd994fd205d929e81947	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 67	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f14.raw	a10320d084e9b2552b9c9cdc618d92c4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 68	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f22.raw	72747f25b2a4c8db41175a2ff0bc37d1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 69	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f17.raw	3a6a4e8d13b5b30dfc57c7204e0abe36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 70	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f05.raw	3c4ea90dca208321a7dd284a15e9462c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 71	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f15.raw	3341b713ee39d9200866cb7b96d9730c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 72	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f07.raw	3d5aa9cb30211c2b54b67d1b22b3e82d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 73	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f20.raw	9cd0c70fa1e46eba109c84799b0c8c63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 74	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f06.raw	11e92fcc3f1b39051c4ed33dca32fdd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1990853a-0e82-40b3-a025-91cdc1_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	1990853a-0e82-40b3-a025-91cdc1	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca14c6dd-2069-4bc5-b1f2-6f2297_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR008	GDC: e2549d98-1b68-4c4d-b7f6-311fdd05b260	ca14c6dd-2069-4bc5-b1f2-6f2297	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fe591474-99d7-44d3-be73-c3b8ed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR002	GDC: 029d5599-d239-4163-a12a-2c7eaf88b88b	fe591474-99d7-44d3-be73-c3b8ed	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
01f203fd-e664-4d78-bea0-7c40cf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Unknown	not available	Qualified	not available	03BR013	GDC: 771110e5-c366-4ace-bdd3-a3453e01f6a7	01f203fd-e664-4d78-bea0-7c40cf	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
314de592-f356-4801-8ace-278173_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR032	GDC: c0cef5fc-0c80-4812-aece-97c351747f26	314de592-f356-4801-8ace-278173	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4683de9c-49ca-4ddd-9d1a-be8121_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	03BR004	GDC: 19b12db3-4dfd-494e-bf60-38d91a7cbad4	4683de9c-49ca-4ddd-9d1a-be8121	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2dc74c29-2e89-4600-80bf-1e3637_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR003	GDC: 328f0b4d-49ef-4295-9560-aa1909118397	2dc74c29-2e89-4600-80bf-1e3637	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 75	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/03CPTAC_BCprospective_Proteome_BC_20160916/03CPTAC_BCprospective_Proteome_BC_20160916_raw/03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	03CPTAC_BCprospective_W_BI_20160919_BL_f19.raw	3ab406a2325b919860e3f1bdfcd11928	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 76	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f14.raw	f5cce186dfd7957977917d883496d78b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 77	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f07.raw	44e4ecee20f60799c6bcd303f0e28e35	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 78	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f10.raw	58bd1fb8522b379eab8a47b00ed8a6a7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 79	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f21.raw	2e5d9a4e8bc0025fd215e1c7be71702f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 80	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f09.raw	86b58cb3cf22bdc36b5798d539cb74f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 81	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f06.raw	7ff5b32646b5c538dd0f7bd8ce2fb723	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 82	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f02.raw	e02362000a3bb8a3f9207f4c9fa08e18	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 83	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f16.raw	d7a258c71253ca7b8876ab53570a1aac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 84	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f17.raw	23305fe95802a95e1c41c0b7cf779e63	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 85	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f04.raw	01f645fcc6e0522d25d2f9fd9d66ce06	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 86	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f08.raw	754bc4abd85ae0417086a81123ae293d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 87	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f12.raw	0bcbe904ce8d142bc69aeba4e17e10ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 88	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f24.raw	d9f6ed3b4f2ddef8ffb02331a75e851d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 89	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f01.raw	3141129e23864a58d49aadc71087ae25	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 90	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f05.raw	9288e49dac99a4fe2a93859ac9be0d10	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 91	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f20.raw	79b8dd738d062d47785384da71aece42	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 92	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f15.raw	1b9d6d3be6b972550b4f2f25aedda973	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 93	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f23.raw	5da4ffea2da48570db99292e63a85222	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 94	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f11.raw	3c6dd8eeea438e3f0c8950d0a49229dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 95	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f18.raw	328320a9fc66bd712fe443ad0cd4f1c9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 96	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f19.raw	dc93fd2093c3e48d02e8bd022e2f35b4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 97	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f03.raw	cd103d1ae572c20ab45bb22edaffa90b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 98	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	04CPTAC_BCprospective_W_BI_20160930_BL_fA.raw	a9bf4deb847c5ffa78e30b0efb115771	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 99	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f22.raw	7de99107947fa73a42927abb3e0537d3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3b177fd6-e7d2-4312-bec7-4a253d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	3b177fd6-e7d2-4312-bec7-4a253d	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b292e992-0611-4254-872f-af8275_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR004	GDC: 2bba44c1-8268-47ff-831a-f96e133c4058	b292e992-0611-4254-872f-af8275	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2f398497-d53e-4838-8006-d60f3e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR005	GDC: 1a7f8669-43c7-479c-95fb-a889365afe53	2f398497-d53e-4838-8006-d60f3e	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5d27516f-58d7-4155-80b4-4c7f39_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	5d27516f-58d7-4155-80b4-4c7f39	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3324361b-df55-4e53-a2ef-4f8df2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR009	GDC: e37910a4-a49c-479b-998a-3b64a15e7942	3324361b-df55-4e53-a2ef-4f8df2	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0edcba67-0714-4b04-b433-77834e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR019	GDC: c94ca480-957d-4deb-ae9a-c2134c7c55e9	0edcba67-0714-4b04-b433-77834e	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
358296ad-e2a7-40cd-849e-8590fd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR001	GDC: f5fadba8-639a-4ed1-9e01-8ce0109a8e89	358296ad-e2a7-40cd-849e-8590fd	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6cb5d29a-9437-430d-b91c-57ee3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR007	GDC: 62282c3f-ead2-4c5f-bcc3-e4a69f7de242	6cb5d29a-9437-430d-b91c-57ee3d	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
94176301-9658-4151-9110-5139de_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	94176301-9658-4151-9110-5139de	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 100	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/04CPTAC_BCprospective_Proteome_BC_20160930/04CPTAC_BCprospective_Proteome_BC_20160930_raw/04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	04CPTAC_BCprospective_W_BI_20160930_BL_f13.raw	27596a8e165f684aa1b98c7d4a87698a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 101	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f11.raw	bfe9e21fd98de4e6adea5ccf5eb157e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 102	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f15.raw	855f4890f8b6670f73435c9115c46cc0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 103	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f21.raw	98d2f1c67f5ebe6580de5f0ba8c626b2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 104	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f12.raw	d991bb45404f8c248e217f7e08995e8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 105	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f05.raw	39c59abd71384a80c537ddced555365b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 106	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f20.raw	4d190ca2090e31326ead7799e10612c0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 107	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f02.raw	20cc3ff61e368138aee2754a52b915a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 108	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f06.raw	ad9013192c28769a0c7aef7fd9697fdc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 109	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f07.raw	dded5a888884ca7efefcd0eeec15aa82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 110	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f24.raw	a585faf3d5c2d22218dc3db5998e1e71	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 111	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f16.raw	4623d1ca7158aff234a0ac5a4dbcd7ab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 112	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f22.raw	4850cd8edf35d26397727a0697c2d5a1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 113	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f10.raw	bb9d1f0775fa8040b9a04fae2b3115f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 114	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f17.raw	d7d27541bffd8e497d2ab4ad1ebe6ba7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 115	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f01.raw	27028f898b9ef32907f3d994ec5215de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 116	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f13.raw	c5eaab8834e994bf85a8c59e74c3bba6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 117	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	05CPTAC_BCprospective_W_BI_20161021_BL_fA.raw	f4a35e1e1dd10534bddf2257bca44393	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 118	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f19.raw	2272cfa284968d66c17a9ebbe6d39713	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 119	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f23.raw	8c40d7b40e07237c8f4423808d555436	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 120	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f04.raw	d3ab403e5529433e89933a46a315ead3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 121	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f18.raw	8c225c43a2a58dca33089fabdb8e052e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 122	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f14.raw	ab3c87c4d1a8db8257a6a410575c317d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 123	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f03.raw	ad98c11506c468d31ddf14c516dbc346	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 124	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f09.raw	4ba8b7af90677a603736987ed6971a84	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
abee08ca-606d-4e2a-a2e6-24780f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	20BR002	GDC: 6489dcd2-c128-42e0-941e-e0a4a931cbda	abee08ca-606d-4e2a-a2e6-24780f	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8dd1d8be-dc7e-44f5-9f44-77ecf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR019	GDC: 4077ccb6-ff96-44c7-b77f-2a548e60de20	8dd1d8be-dc7e-44f5-9f44-77ecf0	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b87e7f88-a1f2-425a-8cff-8ae4b9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	b87e7f88-a1f2-425a-8cff-8ae4b9	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c646b902-e1e0-4e3e-a4c5-daca71_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR033	GDC: 975fdd59-bcd8-4eff-a040-b9c68ebf88b5	c646b902-e1e0-4e3e-a4c5-daca71	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
da3d7876-ca79-4f21-a00e-27e6b6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR022	GDC: 0adbbca3-7efe-42b4-b41a-cbd99239527c	da3d7876-ca79-4f21-a00e-27e6b6	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
faadb553-9437-42cb-b469-498d67_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR013	GDC: 68ec7e12-7f4f-442b-a257-bf61f0819a5a	faadb553-9437-42cb-b469-498d67	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
49f55bd6-a89a-4d18-b732-139c3d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR010	GDC: 83753d99-9074-4fd1-b37d-a2092aeb071a	49f55bd6-a89a-4d18-b732-139c3d	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
547f521a-5851-426c-a125-d9d82c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	547f521a-5851-426c-a125-d9d82c	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fdf0dbe-e05c-465f-8bed-4a92dd_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR031	GDC: afa4d52a-45e6-4efa-96ba-60a9780ffd2c	3fdf0dbe-e05c-465f-8bed-4a92dd	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 125	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/05CPTAC_BCprospective_Proteome_BC_20161021/05CPTAC_BCprospective_Proteome_BC_20161021_raw/05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	05CPTAC_BCprospective_W_BI_20161021_BL_f08.raw	5d9a0160455df212b3c81aed01420e67	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 126	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f02.raw	913c8b7ab92c95107ad6b7864e417818	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 127	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f05.raw	22f3e2c2e35c4785455ef9f7c7dd03c1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 128	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f10.raw	35b7e895e35b059d1cca4636e32b9991	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 129	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f20.raw	9353d741872282b80015d166d6c10ce3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 130	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f15.raw	ac8032550e49429ecc15687e72c025f8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 131	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f19.raw	70ed3b6227c235faa630c918c4d67c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 132	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f23.raw	9e5ee782173c62f4d0e20e449135bc01	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 133	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f11.raw	7e4eddc71b12e0bd72bd46ae000d2760	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 134	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f06.raw	ae281120a9eb2f8e6c3137195c97ae57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 135	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f12.raw	b64262923d625798f4b6461cc1e1c095	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 136	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f07.raw	b91adf79c674d94686693fbfe4d8bf66	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 137	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f01.raw	ecbec88da3cef6ca6ce856191e64aabd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 138	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f18.raw	72ad998ad11fc6cbc035f926881b34de	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 139	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f03.raw	94eeeaa9be564230a902f58de6c255b1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 140	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f14.raw	856338fdd530d72ed70174b78a928f0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 141	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f21.raw	41e6fbc6e6139bc45f455f38c52978b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 142	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f22.raw	fcd7998311e268727b8f9bbae13b04fa	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 143	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f08.raw	22bdc1fe7e3118fa1435f3ba4b952010	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 144	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f24.raw	d700820a698f707aa61fad8f11ed52c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 145	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f17.raw	fff7c6b4730a70ebe75df9459af6dbcc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 146	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f09.raw	e5cfc0970dd830e76800f3fbc1de606f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 147	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	06CPTAC_BCprospective_W_BI_20161116_BA_fA.raw	480dba7c79693f00294a1e1d0ac6f1a5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 148	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f04.raw	0a3450b3534e2fcc2c0aec75fe19b47e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 149	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f16.raw	2f76fe38d032e74553ab44d50ef1246b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
63a05d68-f0f7-42d9-a45f-df0f7e_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	63a05d68-f0f7-42d9-a45f-df0f7e	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1ae5772a-ba49-4c00-b890-7513d0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR007	GDC: 5b3f59e9-2c80-421c-bbdd-7cd5a8b6c6ab	1ae5772a-ba49-4c00-b890-7513d0	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d8a5467b-549b-48ed-9ae5-c9c39d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR050	GDC: 5978194e-dfd2-4666-b716-a0f7d6e36566	d8a5467b-549b-48ed-9ae5-c9c39d	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR001	GDC: 019424bc-fca2-4e61-b272-b0bf0acc4c04	55d3d4bb-0bf5-4b4e-8ef8-d77a5d	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ddc680ad-63cf-4807-b535-9ccc88_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR014	GDC: 71ed013a-1394-45d2-b831-402847049e71	ddc680ad-63cf-4807-b535-9ccc88	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
12110cb8-8da4-4461-ac1a-1af490_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	22BR005	GDC: 007df8da-3d8c-497d-b7d3-3a02596f9577	12110cb8-8da4-4461-ac1a-1af490	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436db08d-c316-44b5-b0de-62617d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR010	GDC: ad641013-add2-4dcc-984b-302e1f35fa1f	436db08d-c316-44b5-b0de-62617d	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c52a27-3d9a-49e7-8ae8-a71e7c_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage III	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR031	GDC: 717b4704-523e-4b75-8bc9-24dde2812c8e	96c52a27-3d9a-49e7-8ae8-a71e7c	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 150	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/06CPTAC_BCprospective_Proteome_BC_20161116/06CPTAC_BCprospective_Proteome_BC_20161116_raw/06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	06CPTAC_BCprospective_W_BI_20161116_BA_f13.raw	71b9d4fc804309d45fe6f2ecbd11bbff	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 151	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f19.raw	5c0786f38105176bb6dfc4f2039f8ede	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 152	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f22.raw	d8d341097cb2b1828a39f8c16d81653d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 153	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f15.raw	f54c6c24e113bd1099cbccef2374858d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 154	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f10.raw	d709e0243e20060c07bec214c6af596b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 155	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f13.raw	bef9897ce449a645141aba8a079f06e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 156	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f21.raw	280ae23f11ca8ce4dd4023dfdba3b568	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 157	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f18.raw	7c3dc319627cfb901c7d365f24e92153	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 158	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f17.raw	8d8784e37530d241f1666bca5ad7564c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 159	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f23.raw	1d7386b85571dbbdf3a4ddd6ec4329dd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 160	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f11.raw	d8b7413081336a535f0d364359bd18ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 161	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f14.raw	25c738ddeea07efa667089a07b061117	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 162	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f08.raw	6da9e7b28d411e45fd12abc928a75dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 163	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f07.raw	3f63dc03d48cf9c6bc361b0889d23472	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 164	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f16.raw	7c24cb31e2570e86468781b23b40a622	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 165	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f01.raw	5c0a220d2c49711d20676d8df455e8e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 166	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f04.raw	035f5134014d71ae00e59c14a1ee8b56	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 167	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f24.raw	4dd43d9ad2df8b4647c8492ac221b2fc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 168	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f05.raw	31a5f94df55373babcaa20690202870a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 169	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	07CPTAC_BCprospective_W_BI_20161119_BA_fA.raw	08de28a56c18ba1522c70a1b40288639	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 170	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f20.raw	6714af745bc373e6c456729530509579	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 171	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f03.raw	f797c196a12e169f7ce6616b150046d6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 172	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f09.raw	b4de8ef4cb8d73ebd7d56c3b53c95d62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 173	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f06.raw	b45ace82fafbd8e694bc1b85a96fcf64	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 174	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f02.raw	31e45e2c65d7b0d6f5eb319f3c6caee5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
96c95de1-514b-44a5-b487-dc390b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR005	GDC: 2ab368b4-f003-4781-866e-52f6a4e65a76	96c95de1-514b-44a5-b487-dc390b	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
436297af-feb7-4754-96b7-c5bfb5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	436297af-feb7-4754-96b7-c5bfb5	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
9efd41a5-3db1-445b-accb-040c2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	9efd41a5-3db1-445b-accb-040c2b	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f957017-d081-45f4-b458-ec3f8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR016	GDC: 152f9e71-a437-4a4b-8c58-3ffcda41904b	3f957017-d081-45f4-b458-ec3f8d	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1f5a9aad-61a1-4a64-a9b0-38cd2b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR030	GDC: 9b82dcc2-d132-48ed-8527-1a54dbb9dbe8	1f5a9aad-61a1-4a64-a9b0-38cd2b	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d154d194-2b08-46d4-a199-84cfb8_D8	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	01BR018	GDC: ce3c8b98-e275-4cfd-a379-940d675a564b	d154d194-2b08-46d4-a199-84cfb8	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8ab1a564-9a18-43bf-aee3-7fceb0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR042	GDC: 4ef2b643-d21d-425c-964c-1d182d8ce53d	8ab1a564-9a18-43bf-aee3-7fceb0	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b10c7b72-1d44-4668-a637-a536b2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR054	GDC: 43536ecc-b3a9-4644-89c8-308e101044f6	b10c7b72-1d44-4668-a637-a536b2	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 175	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/07CPTAC_BCprospective_Proteome_BC_20161119/07CPTAC_BCprospective_Proteome_BC_20161119_raw/07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	07CPTAC_BCprospective_W_BI_20161119_BA_f12.raw	d5045aabe4f508b25b8bca2b1757a787	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 176	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f18.raw	439a04dc93e0638f1200da870179577d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 177	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f13.raw	87a1e96445e24ad2b72b964ef905e070	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 178	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f17.raw	0e880551ece13588959c9c9d251d6ca6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 179	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f10.raw	ee4e224c7a5649b6f978b040d83c87af	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 180	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f19.raw	f0179cc7feb6e180fe72800a3186d0cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 181	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f02.raw	1dd94c9b685a828851a7b79da4d16fa9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 182	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f04.raw	0619986590744da6d12ed471919ee553	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 183	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f06.raw	9ef1327c07a2199b00fda1dbd15cd3e8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 184	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f23.raw	fea109c9e7c43dda088a2831418a1a86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 185	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f08.raw	f18df5e05e588248eb270db6a9d9f7cd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 186	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f07.raw	d6e07cbf40f6c4c3cb4662cf3e9c36b0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 187	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	08CPTAC_BCprospective_W_BI_20170104_BL_fA.raw	26521e1911ef05a8137701ff423b1324	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 188	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f03.raw	b2479a515c1e02a7f050f28f543870b8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 189	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f16.raw	a5f7d633976f7cfbafd49a13bfd9cf51	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 190	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f01.raw	50481f47ff95a6671b4dc54d26f0eef3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 191	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f20.raw	fbb75d3fd64f8a5ef02e95e85e2adc97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 192	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f11.raw	5fdc3a438e7738d4e907a9bbe8ac9c5d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 193	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f15.raw	2fc91d66b51b5086fdf49c583f8e6cb7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 194	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f21.raw	b93b9da9ee038ddcf39331422dcb9bde	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 195	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f22.raw	f601c22f924c0698fc9839a705a8179d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 196	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f24.raw	26800b641584fe8bfb91751a0be6a5ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 197	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f14.raw	e9ffec8f6ab05995ff502aee5e89f1a8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 198	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f05.raw	d7b6d18862f607e8bc568f96dbed61f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 199	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f12.raw	b8c77932b64249bcb3db1517acf41309	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d01714eb-22bf-4ad7-95d9-f95bdf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR044	GDC: aa2186de-7030-4ffd-b7c5-66c6c9cd15c4	d01714eb-22bf-4ad7-95d9-f95bdf	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4798bb9d-7100-43aa-b615-85897d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	4798bb9d-7100-43aa-b615-85897d	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d92a2942-dba6-4fff-b0d0-0566fb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR044	GDC: b05e56ca-a092-489f-90bb-64246cae3e7d	d92a2942-dba6-4fff-b0d0-0566fb	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a7d58d61-5049-488f-9d0a-0a4411_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR016	GDC: 8b14bdf6-b522-4249-80f6-e3a7e8578029	a7d58d61-5049-488f-9d0a-0a4411	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4533a2d6-e850-43f3-9c44-621c07_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR055	GDC: 587c95be-5f0a-45d6-b5fd-f089ea1ffaec	4533a2d6-e850-43f3-9c44-621c07	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
25db2586-55b0-4456-9bba-c24e06_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	not available	Qualified	not available	06BR005	GDC: dce11427-271c-4428-b1ed-a4dfc993d84a	25db2586-55b0-4456-9bba-c24e06	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a176fcc2-97b5-45c3-a0f3-3b2e41_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR042	GDC: 11d2b6ee-9b77-458d-a186-44a097a8055d	a176fcc2-97b5-45c3-a0f3-3b2e41	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
855256a7-e41e-4158-b02f-ba61a9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR018	GDC: 0864cc7a-c9b6-46d0-9018-1e1597df89fa	855256a7-e41e-4158-b02f-ba61a9	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 200	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/08CPTAC_BCprospective_Proteome_BC_20170104/08CPTAC_BCprospective_Proteome_BC_20170104_raw/08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	08CPTAC_BCprospective_W_BI_20170104_BL_f09.raw	09e7440ac28eee3c89c0eef2862c8f44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 201	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f24.raw	bbef3d0ee77e7e8630a7f740ef715857	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 202	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	09CPTAC_BCprospective_W_BI_20170117_BL_fA.raw	639a6895832d37e5b46387d3c0464913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 203	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f14.raw	f4776a52e2553de3de69f3737bcb052b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 204	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f01.raw	303aedad337a9afa365d8217c5803f68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 205	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f21.raw	f52a8b6f67842e08bdf5c9962010eea9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 206	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f20.raw	595690706660464672d7038c6b332a1c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 207	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f16.raw	8ab93490271c75fb81e31296cdc40dd7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 208	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f04.raw	6c7136994068724e8e3d0990aa819057	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 209	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f22.raw	630aee5070c25c41e6cbe0542f9d206d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 210	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f11.raw	74277868fc3ae16a711489fa8406c083	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 211	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f05.raw	ac67de3000cb76e35a845e1518644cc2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 212	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f17.raw	975465afed66711e28d88883ab687066	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 213	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f19.raw	34e66eb30643fd785c83baa92a4e63f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 214	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f10.raw	02753c66447908c1de41eeb9b66cce2a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 215	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f07.raw	ddba4a0c74ea97479a594190ab66f0d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 216	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f08.raw	de2ae9e01e5813424e65678d7456a41a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 217	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f12.raw	97ba8e5b18353e59b1650330566bbba8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 218	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f02.raw	12318dd59d378f3a1ee529f09bfc906b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 219	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f15.raw	f559d3e30a22faec2e6874c8056d740a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 220	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f13.raw	8c43663b41af92545fcbcd682c338b43	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 221	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f06.raw	850bef536a5e8c5721d412de16df2f7d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 222	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f18.raw	3a53c20fb56c9ff708bd54850a9d74a6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 223	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f03.raw	9afc9a76f332b773c59e4da2583ffa89	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 224	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f23.raw	546d872132edec91bc09d22edddb4824	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48d1b543-dbf6-4594-b34a-d0e30a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	05BR009	GDC: aca05259-4b08-413b-a118-9520ccc5a3b4	48d1b543-dbf6-4594-b34a-d0e30a	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d6d42051-ad8e-4fb2-8cfc-829353_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR025	GDC: afae8dce-294a-4108-bb28-376f804ae5c4	d6d42051-ad8e-4fb2-8cfc-829353	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cab796c6-0129-43cf-bd27-7da395_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	cab796c6-0129-43cf-bd27-7da395	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d7b05dce-4362-4e8f-a77a-07dd74_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR040	GDC: 3ce93f85-bd4a-4085-9ac9-77149835e9bd	d7b05dce-4362-4e8f-a77a-07dd74	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
48de7e82-4cba-423c-9e39-89ac6b_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR004	GDC: 7f0a6ddd-1585-4fd6-afe5-ad11b4b4041a	48de7e82-4cba-423c-9e39-89ac6b	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8886aaca-adcf-4416-920a-794bf0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR057	None	8886aaca-adcf-4416-920a-794bf0	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c4015b28-269b-4dc4-8b2e-1b83f7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Not Hispanic or Latino	White	Qualified	not available	01BR043	GDC: 59b8a334-51b4-46f6-868d-c420aaa0eafb	c4015b28-269b-4dc4-8b2e-1b83f7	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ffc76bfb-61f6-4492-a782-c23321_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR003	GDC: 67b32dea-a1e5-4054-b736-cad3905ac795	ffc76bfb-61f6-4492-a782-c23321	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d0ce3c06-9c4c-41bd-b583-9254b0_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	d0ce3c06-9c4c-41bd-b583-9254b0	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 225	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/09CPTAC_BCprospective_Proteome_BC_20170117/09CPTAC_BCprospective_Proteome_BC_20170117_raw/09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	09CPTAC_BCprospective_W_BI_20170117_BL_f09.raw	5b675682c91194353dc60dea91a4dfe1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 226	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f07.raw	5b789199e91b4143b857fa59e61b0f6d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 227	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f23.raw	b76ba80c9d610821237352a7a734faf2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 228	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f24.raw	dc0e0eb7f382b2b552f3982889373cf9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 229	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f14.raw	54b952df784cc717ef148391b0d34043	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 230	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f22.raw	3c401eef152d7af432a0d91455d53162	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 231	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f02.raw	a06d0d126fc79ce806f0a11712bbc1e5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 232	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f09.raw	059ee6b2960f30544ae7eeb119d4b3e0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 233	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f12.raw	c5430e6d8bfb8f294387d11aea8f54cf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 234	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f17.raw	fd01dfbde32c93251f08bff097bb66f4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 235	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f20.raw	41d0989aabe13ced9d8bba7bff924025	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 236	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f18.raw	0a75ddda60908e1db792b7a580201c9a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 237	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f06.raw	17b26519978690449b15ce3338b2a7d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 238	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f10.raw	97a0d81c11c62cc3f7ec276d71ab83f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 239	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f13.raw	2795770f2a2864316d1ad88907f9cad4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 240	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f19.raw	d695e7b192d18212b3a2976bbd41f09c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 241	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f03.raw	614203b4832c026bc4aec376745adbab	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 242	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f01.raw	8b6371e0073805ec6899b4f60beebf8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 243	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f16.raw	9c2e93d9f6147fbe08b272d8e0f6071b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 244	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f04.raw	d4d24027cb7035d018ac1d8259b19578	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 245	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f05.raw	c6ce5218835cfd593108b362e047c73c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 246	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f08.raw	22f8419a9064bfa1b0d9afa5eb145d36	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 247	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f11.raw	9280d598d64d4bb324da428af034ed8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 248	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	10CPTAC_BCprospective_W_BI_20170224_BL_fA.raw	ebbfd31cc19b43175b8ca5efeeaf83c5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 249	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f15.raw	5da1381649419569bcfbe6f9c104a930	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6eaf19bf-dd93-4b0b-93c5-e2bca3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	05BR043	GDC: d89c0960-7290-4f05-a7d9-4b9e1826fc0a	6eaf19bf-dd93-4b0b-93c5-e2bca3	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1e36453-8d78-4247-8c3c-3b2a6f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR026	GDC: 2af3bcd7-505f-4352-9862-8f5f45aa3e63	d1e36453-8d78-4247-8c3c-3b2a6f	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e45c73a8-da96-4269-a039-d43942_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR056	GDC: 30a71873-6790-433e-83d9-7770ff3f52db	e45c73a8-da96-4269-a039-d43942	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4e766d9f-ede3-4311-bf09-b1f9ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR038	GDC: 1a3b63ca-a818-4d0c-bd6f-0c6fd637e1f4	4e766d9f-ede3-4311-bf09-b1f9ba	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5c9ee07a-ca8f-49bf-9c03-2dc513_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR009	GDC: adc1d8b6-a4a2-4cc1-a662-a587e2708ad5	5c9ee07a-ca8f-49bf-9c03-2dc513	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bebb15ad-03f1-4773-b3d4-2f78e3_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR006	GDC: 63bf10ca-59ad-4454-90ce-c7e263b71691	bebb15ad-03f1-4773-b3d4-2f78e3	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
a2637649-1fa1-4c20-a19d-5d5f11_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	22BR006	GDC: d251c783-fc16-4a87-a3bb-5a6f6d77f343	a2637649-1fa1-4c20-a19d-5d5f11	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
59318d66-8b88-45b2-9b97-90e9a7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	11BR072	GDC: 383ccc9f-e0b2-418c-88a2-a803cdab5b7f	59318d66-8b88-45b2-9b97-90e9a7	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 250	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/10CPTAC_BCprospective_Proteome_BC_20170224/10CPTAC_BCprospective_Proteome_BC_20170224_raw/10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	10CPTAC_BCprospective_W_BI_20170224_BL_f21.raw	f5b2fff07ef5965f1d9f525aa1769913	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 251	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f05.raw	780ba9abdaea91bd7257eb9853faad82	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 252	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f22.raw	19a4c6825f039509c1d87be816ce6c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 253	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f13.raw	c9e3d031d3c914ac17be5d74fd91a2df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 254	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f10.raw	cd015dbc8913181a7d4df818be0ed5f3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 255	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f02.raw	1f3bcf316dfe796761e23e1ba7bc1020	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 256	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f16.raw	91a1d2b692764609a038c68ed7ce6276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 257	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f18.raw	c0da7c625cb2b55c62b607c826083c88	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 258	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f21.raw	26800ec8f75a99d46e9093bc45ecd28d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 259	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f15.raw	bd6820c75ed1f4529383a91778df9b0b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 260	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	11CPTAC_BCProspective_W_BI_20170419_BL_fA.raw	d1bd7d947be4b465b83534222db7be9b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 261	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f07.raw	77f6c4c613db9b842a135917d93d1417	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 262	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f20.raw	304b94cfd50485e1edd7aa26fcdf167c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 263	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f08.raw	1cd138dfa55e4b98b1a43b290e0a5e60	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 264	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f11.raw	7ba2694946378ef993b42fd4bb462c68	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 265	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f24.raw	138f1fe60f5cc37619e572dc5d2d8e03	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 266	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f14.raw	8afaf7cb30a05f61856b3148d5923b1a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 267	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f03.raw	2c26639af69816abc6d8ae847c7e630d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 268	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f19.raw	00eea871a9e9d744d15b3197f53231c7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 269	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f09.raw	368effac3e8d84ec1a6e702419c3be05	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 270	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f23.raw	3391a0fd7997ffbe4e3d9a9317cc278f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 271	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f01.raw	8bae152d36ce3e4f86642c2185207de0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 272	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f17.raw	6debfb162f23969c8daf15454c74b1a9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 273	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f12.raw	dadb40b9571191c782c8c32c32da8185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 274	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f04.raw	d590da09ca612f42cb3ce6d650cf0294	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
413d7d87-7b86-4b76-af93-8e8136_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR027	GDC: 3b84fb21-3bfc-449e-9ec8-447b8db21c4b	413d7d87-7b86-4b76-af93-8e8136	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4a25e3da-2226-4e23-a595-c11709_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR040	GDC: 1f6f6c63-1202-4b8c-9b13-f27f9022d556	4a25e3da-2226-4e23-a595-c11709	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fc0aa1e4-c1d8-43ed-a5cd-038f61_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR059	GDC: 5ff51096-968b-480f-a2c7-574279855265	fc0aa1e4-c1d8-43ed-a5cd-038f61	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
56b488cf-a189-47a8-b4e2-d976eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR051	GDC: 39887620-f9ce-44d8-a7e7-0e8721556a80	56b488cf-a189-47a8-b4e2-d976eb	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
942e63bd-84d6-4227-b3de-03e182_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR038	GDC: eb48f7f4-e0a2-4edc-ae4d-c1976e6a6331	942e63bd-84d6-4227-b3de-03e182	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
fb526979-ee2d-4edf-b41d-01074f_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR053	GDC: afe2a69e-3b2e-49a8-9ed9-915d8ad2cc69	fb526979-ee2d-4edf-b41d-01074f	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfc121b5-9562-4a6d-b792-3cd6d5_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	09BR004	GDC: 0ca5d41e-1cd3-4cae-a83e-edfcac4f060f	cfc121b5-9562-4a6d-b792-3cd6d5	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5504c643-4a9c-4ec4-ab07-bebdaf_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR075	GDC: eb4a9253-7a69-4ff8-ad93-8171a5641e70	5504c643-4a9c-4ec4-ab07-bebdaf	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 275	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/11CPTAC_BCprospective_Proteome_BC_20170419/11CPTAC_BCprospective_Proteome_BC_20170419_raw/11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	11CPTAC_BCProspective_W_BI_20170419_BL_f06.raw	553e7db91e5bf1fa4d3fd86f717fe196	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 276	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f16.raw	ee5dffef44b03093806a0ebe6ce96d3b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 277	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f01.raw	00f270ecaad5b335a310dc7b4baf5351	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 278	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f19.raw	60855395949d94e8a465d04abdc8179e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 279	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f13.raw	a46c1bf9265038b722d6e680e4feb317	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 280	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f17.raw	5d584e95789ee2fe95191b87fef5b923	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 281	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f23.raw	2e78563cbe2d5a68b375bc1726f4d0f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 282	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f07.raw	2649d7c02831ab4a2d9fbb6f57478ec3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 283	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f12.raw	e6c4b7a16272f24ab99b998d4fdb990f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 284	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f02.raw	2d07478d927560b5a17c353c3ee8eaaf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 285	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f18.raw	086858a94b2d226d0649f4aa06caa0e3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 286	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f15.raw	9ee44580d7d9c11e35f9fb912a86fd62	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 287	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f06.raw	ea1713e02e022725e8b2d12403021bf8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 288	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f20.raw	ec42e4d81abcfb5724ff313f08dcde80	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 289	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f11.raw	ca089ee01e0bc8e33f34b41f0b184eac	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 290	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	12CPTAC_BCProspective_W_BI_20170428_BL_fA.raw	02899df668bac6e0b7c707cd54623397	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 291	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f14.raw	a6d0faed8c3ae2f552d8965198b09d7c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 292	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f05.raw	76ea77da9e9115d08de6b5f1cfba8108	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 293	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f10.raw	76c337672f0efd536c838477a4791e20	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 294	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f22.raw	08ab440803b4f22cb42571cca98a1217	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 295	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f08.raw	f9bae46c8bcac5221c359fb27dcbe05a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 296	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f04.raw	920e0940234b730d6ebbc2fd83721cd0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 297	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f24.raw	5b65b76b50ac85788843c415c1bc4e44	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 298	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f09.raw	2d71779e881b8e1e95af0c431ccb68a3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 299	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f03.raw	1c5c6f5369b5c9b674c3d593adf01160	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
ca576d30-be91-4bf5-a31d-80f7eb_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	03BR002	GDC: d550ffeb-5655-4f30-9437-4374c8ea38d1	ca576d30-be91-4bf5-a31d-80f7eb	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
8c9232b9-bd06-4474-8236-70dd8a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	11BR078	None	8c9232b9-bd06-4474-8236-70dd8a	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7557b796-f11c-4077-a1af-b249c8_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIC	Female	Not Hispanic or Latino	White	Qualified	not available	16BR012	GDC: 1de87b90-c404-4b01-aa3c-5a91f987c8bd	7557b796-f11c-4077-a1af-b249c8	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
b2d62dca-3741-4d59-92b8-bdcfed_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Hispanic or Latino	not available	Qualified	not available	06BR014	GDC: f603ce39-4669-4b91-b3ab-41afb51d3f6c	b2d62dca-3741-4d59-92b8-bdcfed	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT001846-0005	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	Unknown	White	Qualified	not available	01BR044	GDC: f2752dae-cad9-486d-95cf-dcbde49936ea	CPT001846	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
5a9e89e9-4ac6-4c2f-b05e-c956ba_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	not available	not available	not available	Qualified	not available	11BR076	None	5a9e89e9-4ac6-4c2f-b05e-c956ba	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3bbf4310-6a83-4d3b-8772-a5dbb6_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR016	GDC: 8474446e-55b6-4acf-8a6c-4ecaf20e789c	3bbf4310-6a83-4d3b-8772-a5dbb6	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6838157f-361d-4e95-b933-35bd46_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR005	GDC: 6870f4c7-9a54-4e57-aaa8-08d7e40ece2f	6838157f-361d-4e95-b933-35bd46	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 300	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/12CPTAC_BCprospective_Proteome_BC_20170428/12CPTAC_BCprospective_Proteome_BC_20170428_raw/12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	12CPTAC_BCProspective_W_BI_20170428_BL_f21.raw	8d08dda7ce2012913dedbb0d2b94092d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 301	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f21.raw	8913a12d703cd385810e173aa99c543d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 302	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f12.raw	d57d3c33b20a1fae3e1125ff521c2a95	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 303	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f17.raw	98a75a5a3e98b75920c4338505ed745f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 304	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f02.raw	56355e4ab1c01260365765112fcdfeb6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 305	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f01.raw	8f6b71420f28375c08b40785e2253d5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 306	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f07.raw	c0d4c5679d7407d501f81f672d458eae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 307	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f24.raw	804f080ff8a3244f6a37848fa2a45c4a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 308	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f06.raw	aefe10e09afe87541fcd8483e46347e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 309	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f15.raw	51f3e57824adb59551be4dbeb62a842b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 310	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f03.raw	f53e450f858f3908d253a9d9afcaa83b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 311	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f22.raw	ac7bca6a2f73ccd14ef2a91e76cc2f57	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 312	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f23.raw	9ccc16094af2c08a680a3ad0f2305968	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 313	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f20.raw	dc82be82576310631b872c447f578a59	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 314	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f08.raw	2f54184c9c47bf8ac2d6328fab6ad414	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 315	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	13CPTAC_BCProspective_W_BI_20170527_BL_fA.raw	a50baa92b3f65ba63292a3f949015e40	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 316	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f14.raw	a269961a196fde9e51e8e2b2c7fefbd6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 317	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f04.raw	3c7b99de3bfb93cbd2d168a7ce3cbc91	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 318	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f11.raw	4810553a5095ff39dab1582742fd898d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 319	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f10.raw	f39bfabbd9f99d37c5e999a675f3953c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 320	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f09.raw	e7811de4c260b03daac12bed88412795	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 321	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f13.raw	e609412632de4bba1bf447215e83113d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 322	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f19.raw	142bac3db0802b199434df0f8d52c93f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 323	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f18.raw	66f8280a8a2bb084ec5095ff3e37c93a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 324	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	13CPTAC_BCProspective_W_BI_20170527_BL_f05.raw	c34734beec6240cecb470b100db4e9c6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
878c2524-208e-40b2-8089-ceb820_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	White	Qualified	not available	13BR009	GDC: 629551c4-ee46-4d2c-9b34-e6d9245b83ad	878c2524-208e-40b2-8089-ceb820	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e2c7113f-957f-4088-b57d-55d2f2_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	11BR080	GDC: df839822-120c-457e-a9e1-0a0fdef8665f	e2c7113f-957f-4088-b57d-55d2f2	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
CPT000814-0004	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	Female	not available	Black or African American	Qualified	not available	604	GDC: 7a802e34-3e39-4e87-86c3-15bc90338d55	CPT000814	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4df35993-eab6-4289-822c-d77da9_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage II	Female	Unknown	Black or African American	Qualified	not available	01BR042	GDC: 8afe366c-aa0a-435d-ad3f-f82910b447fc	4df35993-eab6-4289-822c-d77da9	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
433c2eb6-560f-4387-93af-6c2e1a_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	15BR003	GDC: a0bfef36-6e6f-4d61-8f50-b379aa96c8ac	433c2eb6-560f-4387-93af-6c2e1a	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
d1034660-11ce-4e38-9ad0-8b9b72_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	not available	White	Qualified	not available	14BR014	GDC: 5576ffbb-4968-40f2-a401-847ef581eacc	d1034660-11ce-4e38-9ad0-8b9b72	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
80a970f7-7b36-4450-aff8-0b55dc_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR058	GDC: b6d07707-90e4-4356-8011-10ddb28ce567	80a970f7-7b36-4450-aff8-0b55dc	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
98225215-ff21-4893-8b6d-d9b7e7_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR012	GDC: d1b16f15-66a6-49fa-ba51-6f21e4af77f1	98225215-ff21-4893-8b6d-d9b7e7	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
RetroIR	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	RetroIR	None	RetroIR	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 325	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/13CPTAC_BCprospective_Proteome_BC_20170527/13CPTAC_BCprospective_Proteome_BC_20170527_raw/13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	13CPTAC_BCProspective_W_BI_20160257_BL_f16.raw	85428c4aa58c3931e92159b5bbb1c90c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 326	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f02.raw	7bde97da339478719021b1c4bc3e5f0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 327	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f14.raw	2314abfb16f65ef81253bf317ab9b719	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 328	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f06.raw	ba8c2c561d4254d214b7a7f7450ea798	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 329	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f21.raw	2ac66764dafab4705b257f4c8b5d3b96	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 330	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f11.raw	b91810a78bf4edd29977722daf87b303	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 331	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f24.raw	32bf4952da5b5b0bfab8d3526b536685	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 332	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	14CPTAC_BCProspective_W_BI_20170602_BL_fA.raw	cb4ee3c303b8c3122dd8c6c0b5e62e86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 333	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f01.raw	53e626bbe8def555e110ae1931c03177	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 334	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f10.raw	72a443ceb343b61bde2995de785d42d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 335	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f08.raw	2e0c174e59edbdeb817769787c660ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 336	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f03.raw	be4b7b235db885bc20a8d4c9f4a92848	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 337	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f05.raw	1fbd442f3ce3395391efe304cb779024	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 338	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f22.raw	80a8584e1918a5171e4fecf8a0b83473	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 339	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f16.raw	63bfefebaf1eb8313f78c36d46988e21	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 340	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f13.raw	e03cf7bbc68a24a853a62694322076c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 341	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f23.raw	ff2331803dfa84010a5b5d72bf4418b9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 342	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f17.raw	b2f90b96fd0239510e887b9b3a1951d8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 343	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f18.raw	9c4e93e3eb18d116f0f2345611b42d8e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 344	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f07.raw	910268bd0a0de18ac134671d0bd5c089	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 345	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f09.raw	c34240355acf72a29d031766e31106e6	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 346	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f12.raw	20a4c5d36fbc00aa96197d1980323d46	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 347	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f19.raw	382da8ff2d48019874315932d80a34f2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 348	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f04.raw	7deee994541001a054948e482a1bdce4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 349	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f20.raw	69cda448b75d6ace8aefde3698fb94cb	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3367406e-d39c-4641-a3e7-44e1f3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR074	GDC: d5d39517-70df-414f-b3a9-d29c3bf0e5a6	3367406e-d39c-4641-a3e7-44e1f3	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1664b920-5e60-4e3b-9aab-fe121c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR073	GDC: 99aac7ae-4f88-459e-9c2c-c56ac7b44d8f	1664b920-5e60-4e3b-9aab-fe121c	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
33adae13-5dbd-4530-a5d5-3763e4	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR007	GDC: 1eef079e-d5cd-4a0c-a9b5-525865aa7847	33adae13-5dbd-4530-a5d5-3763e4	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
39f81c85-1832-45eb-829a-3040ad	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	39f81c85-1832-45eb-829a-3040ad	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
241ecd0e-89bd-4d3a-81b3-55a250	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR017	GDC: 5e0774ff-d53d-45d3-b8d7-b0e7f7a72a9d	241ecd0e-89bd-4d3a-81b3-55a250	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
7ac27de9-0932-4ff5-aab8-29c527	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	05BR029	GDC: 195089d6-f4c3-4c07-8409-40bb7c2626d8	7ac27de9-0932-4ff5-aab8-29c527	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
e3d45dc6-66ef-4e0b-9d96-1b5db5	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	18BR003	GDC: da26a094-aecd-4553-8848-985da04eee66	e3d45dc6-66ef-4e0b-9d96-1b5db5	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
4749ba99-d3b8-4ae3-b6f6-458bc7	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR030	GDC: 8f201354-29ea-41ea-b1ec-71525b272f3f	4749ba99-d3b8-4ae3-b6f6-458bc7	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
64ee175f-f3ce-446e-bbf4-9b6fa8_D1	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	01BR027	GDC: f6157b6e-e5c7-480a-bdc6-62f7d36a649c	64ee175f-f3ce-446e-bbf4-9b6fa8	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 350	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/14CPTAC_BCprospective_Proteome_BC_20170602/14CPTAC_BCprospective_Proteome_BC_20170602_raw/14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	14CPTAC_BCProspective_W_BI_20170602_BL_f15.raw	5a6d37e974eac64f1aa88c8790a466cc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 351	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f17.raw	2357f64bd9f63f0f649f2b8356308d86	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 352	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f12.raw	47c7687c87f219500b79c8483aaf2a6f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 353	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	15CPTAC_BCProspective_W_BI_20170606_BL_fA.raw	c37002b876babe92a6b4829960a1b8fe	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 354	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f21.raw	5df5fa2b1b18f36360b9e46ab0eff3e4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 355	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f02.raw	fa65ae180612b46252cac24c63e79d0a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 356	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f04.raw	a5c04c25923217db4703db6fa3baec4e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 357	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f06.raw	213b6c0e148e933bad3a9892249f36bf	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 358	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f08.raw	377fdee5fdb1ade6f3d8b15c502b0889	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 359	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f01.raw	2899bcc0a2abbe8c28d54ba302f633e9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 360	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f19.raw	54a56e6ea20e1a0790bd57890a4fc302	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 361	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f15.raw	7767f732ab1208debc60eb4cc9cbbbc1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 362	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f20.raw	c57aaef3c201a549893fd4bf3fab944b	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 363	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f07.raw	7bfa41441f8e6c9de88f3cc250074084	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 364	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f24.raw	6bac63da33dc34fec0b8bbde33bdbe1e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 365	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f22.raw	c5116724876af8d4aed60fba863c373d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 366	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f23.raw	1d74c7518bd098e002e16e7097899da1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 367	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f18.raw	917c86418b193c3bbf4516455c02f15c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 368	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f11.raw	f4501af6365d917c0af984df28714e04	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 369	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f09.raw	6ee004c09a0355d73ad9aa1072485dc9	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 370	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f03.raw	e42b362e9ed6418d24ea0b24f7a6a9ae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 371	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f10.raw	b7260fd510d359030403edce498386c8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 372	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f13.raw	8b7516f8101d4bd51c59ba4c11c6a62c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 373	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f05.raw	34596c768d67ae99be92d51b1280abd5	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 374	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f14.raw	5f2a4b2c50129ccd6a360d56b9e6efae	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1740224c-32d1-4c9f-98c6-653363	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR025	GDC: f61c2eb6-c7a9-4831-9f42-1cc2a68d441b	1740224c-32d1-4c9f-98c6-653363	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
81116212-b7e6-454b-9579-105cf3	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR047	GDC: 41e4a515-77b3-42f1-ab2a-ce8c4648f8e5	81116212-b7e6-454b-9579-105cf3	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
885fe794-a98e-4f81-a284-ac4bb8	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR028	GDC: 937e9453-e195-42a6-820c-4b3d62797a89	885fe794-a98e-4f81-a284-ac4bb8	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
428de0d4-7f84-4075-bae1-352af6	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR020	GDC: 2cdf166f-eaf4-4347-ad5e-aca8c2ffb394	428de0d4-7f84-4075-bae1-352af6	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
acf022b3-7f01-43b3-ac14-86f97d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIB	Female	Not Hispanic or Latino	Black or African American	Qualified	not available	20BR008	GDC: 35920ef3-51ee-47f7-af63-2e278cc33951	acf022b3-7f01-43b3-ac14-86f97d	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
53723086-8858-4395-93d7-0baa68	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR024	GDC: 13b5719b-8dd1-4b2a-871f-8bed2cf48d34	53723086-8858-4395-93d7-0baa68	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0a80d3c4-0758-447a-958c-ea868c	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR023	GDC: 533b908a-e79e-4f77-8fae-ad6a21fa3f25	0a80d3c4-0758-447a-958c-ea868c	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
6c660b6b-bfda-47b0-9499-160d49	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	White	Qualified	not available	11BR015	GDC: 86118217-85bd-4b8e-9995-ddeaa87722f6	6c660b6b-bfda-47b0-9499-160d49	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3208e021-1dae-42fd-bd36-0f3c3d	Homo sapiens	Breast	Solid Tissue Normal	Solid Tissue Normal	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR006	GDC: 1cc8a9c8-d8f6-4803-96a0-ecbfe5e0da22	3208e021-1dae-42fd-bd36-0f3c3d	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 375	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/15CPTAC_BCprospective_Proteome_BC_20170608/15CPTAC_BCprospective_Proteome_BC_20170608_raw/15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	15CPTAC_BCProspective_W_BI_20170606_BL_f16.raw	b2198c64722d98d8424e840857228ff8	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 376	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f02.raw	438d28cfb41e98db67a5badabb338c5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 377	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f15.raw	525355c0c6c4b6cd81d6dca89b2bf231	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 378	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f16.raw	872e098501060d7785edd5d4671e25d2	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 379	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f06.raw	21402b93fddda5b5c7eaa042fe6d9715	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 380	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f07.raw	11fc328e1706cf354be6ee7453674c73	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 381	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f18.raw	b06988740d0d2cb97f44e0a1451d5e58	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 382	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f12.raw	b65291fddea99d4bc0e75fce57e158d4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 383	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f10.raw	a8deb8707c5171e6134637a05be8fc5c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 384	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f11.raw	fe6f758663bd58c70957a290789661df	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 385	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f01.raw	04c97e465d59d407b1ea4437485c5078	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 386	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f21.raw	6c6e8d2a4c8b61aeb0d55a451acf89e1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 387	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f09.raw	04d2728efeb8b3e042b0e741bc6ba390	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 388	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f08.raw	697ed99c3d5c2ed4ad339ca018bef92e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 389	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f03.raw	b0bc5c6d9822d184916af8f44dc6cb3f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 390	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f22.raw	efd53b2a2cec1d71be7a75be70d2ef97	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 391	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f05.raw	a2581583bac22f39a686ca6482882077	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 392	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f19.raw	1cb47b71b3d44c023f8dbaf3b7b65080	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 393	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f04.raw	6129f5fca5d789553a76781a0a8c4185	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 394	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f23.raw	afcc8ef205b464dcdf3951a3527f607e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 395	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f13.raw	f6214dd537a32917be25575cc8e3e4f1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 396	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f24.raw	9393cb5ab9f04c709a9169a29122acb1	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 397	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	16CPTAC_BCProspective_W_BI_20170609_BL_fA.raw	b7a09b918cb5b66b50da39fadd895e4c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 398	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f20.raw	241093d1dad9d08fd60d2542b45ca927	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 399	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f17.raw	c902d9a5f23e6d45c64476f055d6c2d7	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
97cc4d46-cf80-41f1-b99c-bc4829_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR060	GDC: efd0c8b6-ae7c-44cd-81fd-aaba58d83c2f	97cc4d46-cf80-41f1-b99c-bc4829	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
0ecabbfa-8095-4875-acdb-051582_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR009	GDC: 16614d46-172b-479c-992b-e80a8e9a2c59	0ecabbfa-8095-4875-acdb-051582	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
cfa2809f-5468-4457-870c-467c39_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR008	GDC: e6915db0-7c89-484d-8f9f-15cca68b82fc	cfa2809f-5468-4457-870c-467c39	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
1fb9fca2-cf63-41f2-9381-d9108c	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR001	GDC: 271ff03f-1367-4654-9d67-4456e1ff4eb3	1fb9fca2-cf63-41f2-9381-d9108c	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
32944ee6-428e-44fc-97d6-22665e	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	21BR002	GDC: fbad4165-ac84-44ed-8688-47f93fee5957	32944ee6-428e-44fc-97d6-22665e	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
884659ef-cce7-4b4a-b28b-0e1f49	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	01BR026	GDC: f8400a0c-624e-48fa-8a18-e4fe04eebcac	884659ef-cce7-4b4a-b28b-0e1f49	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
71e07184-b085-4d3d-aabf-6e1420_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	05BR004	GDC: 9e2600ab-06f2-450c-98ab-9776197fe80b	71e07184-b085-4d3d-aabf-6e1420	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
071be0fb-b7fd-4165-b3c5-348352	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR006	GDC: a8792151-962d-4fd8-ac94-2761a52d9406	071be0fb-b7fd-4165-b3c5-348352	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
2386c36d-8d5d-4fd4-bbfa-39cc8d_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	White	Qualified	not available	14BR005	GDC: 4eddfec9-b5aa-4768-8bbc-329d474a514b	2386c36d-8d5d-4fd4-bbfa-39cc8d	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 400	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/16CPTAC_BCprospective_Proteome_BC_20170609/16CPTAC_BCprospective_Proteome_BC_20170609_raw/16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	16CPTAC_BCProspective_W_BI_20170609_BL_f14.raw	5829d1a790486609a64b5caf6eaa4ff4	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 401	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f24.raw	90e0a5236a41135e92973e8fe0487ffc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	24	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 402	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f10.raw	3c5111c7746d910f8d948ae4eb0dc3ee	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 403	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f21.raw	8061eb28d43673231eea72a2d6c3845a	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	21	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 404	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f02.raw	ea62c3f6be7b66fa3174d06abc05920f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 405	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f11.raw	72d089a25273fb1a0af0184550ccdcbd	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 406	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f13.raw	9b98fef86f1c2f87224d8d1af55a45ce	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 407	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f07.raw	347986bd115b73ae180e029ed47d4f1f	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 408	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f12.raw	d5ea9dac794f8f460d3978bbe3f67258	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 409	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f19.raw	77a652d7846c0d8df43fee4b7950514e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	19	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 410	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f04.raw	b3b04f8cc7af31e072db252d35ebb4dc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 411	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f08.raw	4bf7a4867ec96764c2c9d0e076e916c3	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 412	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f03.raw	0e7d83201617898431f704362f370894	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 413	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f16.raw	0fa2cb00ae6a62cc62be2e74a1ad8b38	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	16	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 414	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f18.raw	d2ac302e6bf2a4fd909d97af9b77d94d	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	18	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 415	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f09.raw	20419e51e28dc1dbcfc6aa2c778d8678	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 416	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f14.raw	e2e3d9f17d0d9bfa5834ed66766fdd0e	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 417	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f05.raw	f72956b4983ad92aed825f565ee28296	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 418	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f01.raw	3d33a1c8ad41a40ce956af6f06d73811	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 419	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f20.raw	8ef2f1dab399fb3f2ae323ca22715276	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	20	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 420	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f15.raw	86c3a44e0e46eb6bdbaff1a1e6744abc	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 421	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f06.raw	f7b500ada14439d8b85d68732b320c93	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 422	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f17.raw	275ad2e60646817ccca4bf965841b4d0	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	17	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 423	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f22.raw	af1973177c7a1b96bc1c06e13c896464	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	22	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 424	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	17CPTAC_BCProspective_W_BI_20170613_BL_fA.raw	9673206a3b5bb960e7cd2e184c9a912c	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	A	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
c875a9a4-035f-425a-9348-26129c_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR023	GDC: 19d3c861-8a5f-49a2-acc0-b55b25465c35	c875a9a4-035f-425a-9348-26129c	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT126	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
bc9fe67f-c4a2-43ba-87bd-438bda_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR011	GDC: 20527e43-a185-4a21-9ac9-f9603bba54c9	bc9fe67f-c4a2-43ba-87bd-438bda	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3fd68501-514a-4a30-9ce1-2fca26_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR020	GDC: e4ce89ef-bcaa-418a-8a6b-3602793b9bbf	3fd68501-514a-4a30-9ce1-2fca26	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT127C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
3f52e236-1daa-4aa0-9a77-e3d043_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIB	Female	Not Hispanic or Latino	White	Qualified	not available	20BR006	GDC: f49a5dc1-7138-4f09-a3d1-0df641e4004a	3f52e236-1daa-4aa0-9a77-e3d043	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
68ef4aa9-00b0-4528-8828-4d3e43_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Hispanic or Latino	White	Qualified	not available	21BR010	GDC: f519900c-de82-4aff-9a19-c7c645c2a834	68ef4aa9-00b0-4528-8828-4d3e43	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT128C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
20506075-36a7-4754-8e5e-628918	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	09BR001	GDC: e3c49ac5-d5eb-4b88-8a71-5f43494470c7	20506075-36a7-4754-8e5e-628918	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
60c8c914-f53d-4f72-a1ce-5fb803	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available		not available	not available	not available	Qualified	not available	03BR011	GDC: 4b355c1d-4202-4291-93ec-7882e702bd20	60c8c914-f53d-4f72-a1ce-5fb803	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT129C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
45b99ac4-0859-4a3d-8b1e-ce5590_D2	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Stage IIA	Female	Not Hispanic or Latino	Asian	Qualified	not available	11BR036	GDC: f82b8134-65bc-47f5-9627-ca8b6ed9fc8b	45b99ac4-0859-4a3d-8b1e-ce5590	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130N	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
26ecef2d-fcf3-4b85-9647-5e5d29_D1	Homo sapiens	Breast	Primary Tumor	Primary Tumor	Breast Invasive Carcinoma	not available	Not Received	not available	not available	not available	Qualified	not available	01BR010	GDC: 567fc9e3-17a6-42b1-a896-5e9a9507d1d8	26ecef2d-fcf3-4b85-9647-5e5d29	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT130C	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
Internal Reference - Pooled Sample	Homo sapiens	not available	not available	not available	Other	not available	Not Received	not available	not available	not available	None	not available	Internal Reference - Pooled Sample	None	Internal Reference - Pooled Sample	run 425	proteomic profiling by mass spectrometry	NT=Orbitrap Fusion Lumos;AC=MS:1002732	TMT10	https://cptc-xfer.uis.georgetown.edu/publicData/Phase_II_Data/CPTAC_Breast_Cancer_S039/17CPTAC_BCprospective_Proteome_BC_20170613/17CPTAC_BCprospective_Proteome_BC_20170613_raw/17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	17CPTAC_BCProspective_W_BI_20170613_BL_f23.raw	90842f143342d46337a4ff131d5167ba	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	23	TMT131	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	not available	AC=MS:1000422;NT=HCD	38% CE	not available	not available
